Development and Technology of mRNa Vaccines and Therapeutics beyond COVID-19

book chapter (2026) Development and Technology of mRNa Vaccines and Therapeutics beyond COVID-19. 34.

[thumbnail of Chap 4 35-44.pdf] Text
Chap 4 35-44.pdf - Published Version

Download (569kB)

Abstract

This study is based on the application of mRNA vaccines for the
treatment of various infectious diseases and different cancer types.
An mRNA vaccine is a new type of vaccine that introduces cells into
the human body that produce harmless protein to trigger the
immune system to develop immunity-producing antibodies against
antigens. These vaccines were developed after the global outbreak
of COVID-19. This significantly helped the scientists to invent
vaccines in a short period of time compared to the traditional
vaccines. The main role is to reduce the death rate by controlling
the spread of disease. In the case of cancer, mRNA vaccines help the
immune system to recognize and destroy the cancer cells by
producing the tumor-specific antigens. In order to create targeted
mRNA technology, including its applications in vaccines,
immunotherapies, protein replacement therapy, and genome editing
as well as its distribution to particular cell types and organs

Item Type: Patent
Subjects: Pharmaceutics > Drug Delivery System
Domains: Pharmaceutics
Depositing User: Mr IR Admin
Date Deposited: 11 May 2026 07:10
Last Modified: 11 May 2026 07:10
URI: https://ir.vistas.ac.in/id/eprint/16420

Actions (login required)

View Item
View Item